360biolabs supports the first Australian COVID-19 clinical vaccine trials
28 April 2020 In one of the first COVID-19 clinical vaccine trials, US-based clinical-stage biotechnology company Novavax (NASDAQ: NVAX) has selected Australian speciality laboratory 360biolabs, to conduct sample analysis for the clinical trial of its SARS-CoV-2 recombinant spike…
Biotech Daily More Excellent News Flash: Biotech Bounces Back In April
1 May 2020 The BDI-40 (which does not include the three Big Caps of Cochlear, CSL and Resmed) recovered most of its Covid-19 Pandemic global downturn losses in April, up 26.7% to $13,953 million – above its August…
Survey of the Health and Medical Research Sector to explore the impact of COVID-19 restrictions on research in Australia
30 April 2020 Research Australia is working to compile a comprehensive report for Australian governments to fully understand the impact COVID-19 is having on the sector. This brief survey is designed to gain insight into the impact of…
New genes linked to severe childhood speech disorder
30 April 2020 An international study led by Melbourne researchers has discovered nine new genes linked to the most severe type of childhood speech disorder, apraxia. The research analysed the genetic make-up of 34 affected children and young…
Helping health professionals communicate in the era of COVID-19
27 April 2020 The University of Melbourne‘s “Communicating COVID-19″ course is designed for a wide range of healthcare providers both in hospital and community settings and will help provide expert-informed answers to questions Australian health care practitioners face surrounding…
Free access to Clarivate’s BioWorld coronavirus articles
30 April 2020 Clarivate have provided free access to COVID-19 content in their BioWorld suite of news services. Viewers can access general news as well as three critical tables summarising: Vaccines and therapeutics in development Diagnostics on the…
Personalised nutrition smart patch to be developed in Australia
27 April 2020 A wearable smart patch will deliver precision data to help people personalise their diets and reduce their risk of developing lifestyle-related chronic diseases like Type 2 diabetes. The world-first personalised nutrition wearable being developed by…
Offspring may inherit legacy of their father’s Toxoplasma infection
29 April 2020 Melbourne researchers at the Walter and Eliza Hall Institute have revealed for the first time that males infected with the Toxoplasma parasite can impact their offspring’s brain health and behaviour. Studying mice infected with the common parasite Toxoplasma,…
Cracking the COVID-19 immunity code
29 April 2020 Monash University’s Dr James McMahon, an infectious disease expert and hospital clinician at The Alfred and Monash Health, is leading the development of a biobank aimed at cracking the immunity code of COVID-19. The biobank enables…
Immutep Reports Positive Phase II TACTI-002 Data
28 April 2020 Immutep Limited (ASX: IMM; NASDAQ: IMMP), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, announces further positive interim data from its ongoing Phase II TACTI-002 study. The data relates to the…
New type of immune cell discovered in breast ducts
28 April 2020 Melbourne breast cancer researchers have discovered a new type of immune cell that helps to keep breast tissue healthy by regulating a vital process within mammary ducts – the sites where milk is produced and…
Researchers create world’s first ultrasound biosensor
23 April 2020 Australian researchers have made a world-first breakthrough that has the potential to monitor the changes in pH levels and other responses to therapy in stroke and cancer patients. Researchers from Monash University and the Baker…
